ACXP: Acurx Pharmaceuticals Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Acurx Pharmaceuticals Inc (ACXP).
$13.75M Market Cap.
ACXP Market Cap. (MRY)
ACXP Shares Outstanding (MRY)
ACXP Assets (MRY)
Total Assets
$3.86M
Total Liabilities
$3.24M
Total Investments
$0
ACXP Income (MRY)
Revenue
$0
Net Income
-$14.10M
Operating Expense
$14.10M
ACXP Cash Flow (MRY)
CF Operations
-$10.38M
CF Investing
$0
CF Financing
$6.62M
ACXP Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $3,857,963 (-49.96%) | $7,709,123 (-17.78%) | $9,376,706 (-29.25%) | $13,254,150 (311.11%) |
Assets Current | $3,857,963 (-49.96%) | $7,709,123 (-17.78%) | $9,376,706 (-29.25%) | $13,254,150 (311.11%) |
Assets Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $615,121 (-86.82%) | $4,666,685 (-36.20%) | $7,315,021 (-41.06%) | $12,410,241 (359.37%) |
Property Plant & Equipment Net | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cash & Equivalents | $3,706,713 (-50.41%) | $7,474,188 (-17.97%) | $9,111,751 (-29.69%) | $12,958,846 (308.10%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $51,127 (-60.42%) | $129,159 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $3,242,842 (6.59%) | $3,042,438 (47.57%) | $2,061,685 (144.30%) | $843,909 (85.10%) |
Accumulated Retained Earnings (Deficit) | -$67,321,956 (-26.50%) | -$53,218,853 (-37.73%) | -$38,641,085 (-45.55%) | -$26,548,309 (-92.37%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Debt Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Debt Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Liabilities | $3,242,842 (6.59%) | $3,042,438 (47.57%) | $2,061,685 (144.30%) | $843,909 (61.53%) |
Liabilities Current | $3,242,842 (6.59%) | $3,042,438 (47.57%) | $2,061,685 (144.30%) | $843,909 (78.58%) |
Liabilities Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
ACXP Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $8,699,267 (1.93%) | $8,534,171 (16.29%) | $7,338,505 (-31.95%) | $10,784,023 (349.89%) |
Research & Development Expense | $5,403,836 (-10.59%) | $6,043,597 (27.12%) | $4,754,271 (134.18%) | $2,030,177 (-7.84%) |
Operating Expenses | $14,103,103 (-3.26%) | $14,577,768 (20.55%) | $12,092,776 (-5.63%) | $12,814,200 (178.57%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$14,103,103 (3.26%) | -$14,577,768 (-20.55%) | -$12,092,776 (5.14%) | -$12,747,697 (-177.12%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$14,103,103 (3.26%) | -$14,577,768 (-20.55%) | -$12,092,776 (5.14%) | -$12,747,697 (-177.12%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$14,103,103 (3.26%) | -$14,577,768 (-20.55%) | -$12,092,776 (5.14%) | -$12,747,697 (-177.12%) |
Weighted Average Shares | $808,168 (27.56%) | $633,579 (17.15%) | $540,821 (26.72%) | $426,794 (37.88%) |
Weighted Average Shares Diluted | $808,168 (27.56%) | $633,579 (17.15%) | $540,821 (26.72%) | $426,794 (37.88%) |
Earning Before Interest & Taxes (EBIT) | -$14,103,103 (3.26%) | -$14,577,768 (-20.55%) | -$12,092,776 (5.14%) | -$12,747,697 (-177.12%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$14,103,103 (3.26%) | -$14,577,768 (-20.55%) | -$12,092,776 (5.63%) | -$12,814,200 (-178.57%) |
ACXP Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow from Financing | $6,615,956 (-18.96%) | $8,163,322 (120.92%) | $3,695,195 (-75.03%) | $14,797,132 (265.94%) |
Net Cash Flow from Operations | -$10,383,431 (-5.94%) | -$9,800,885 (-29.95%) | -$7,542,290 (-50.43%) | -$5,013,697 (-49.59%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$3,767,475 (-130.07%) | -$1,637,563 (57.43%) | -$3,847,095 (-139.32%) | $9,783,435 (1313.61%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $6,405,757 (7.76%) | $5,944,250 (60.86%) | $3,695,182 (-75.03%) | $14,797,132 (272.05%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $2,601,903 (-18.86%) | $3,206,527 (11.66%) | $2,871,681 (-52.70%) | $6,071,479 (310.92%) |
Depreciation Amortization & Accretion | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
ACXP Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -444.00% (-53.26%) | -289.70% (-118.97%) | -132.30% (-15.95%) | -114.10% (56.33%) |
Return on Average Assets (ROAA) | -221.00% (-19.33%) | -185.20% (-56.55%) | -118.30% (-12.88%) | -104.80% (34.42%) |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | 468.30% (-13.88%) | 543.80% (-62.44%) | 1447.70% (-33.41%) | 2174.20% (377.64%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% |
Price to Earnings Ratio (P/E) | -0.94 (71.89%) | -3.33 (6.30%) | -3.55 (-22.55%) | -2.9 |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | 22.35 (97.82%) | 11.3 (79.17%) | 6.31 (77.31%) | 3.56 |
Debt to Equity Ratio (D/E) | 5.27 (708.59%) | 0.65 (131.21%) | 0.28 (314.71%) | 0.07 (-64.77%) |
Earnings Per Share (EPS) | -17.4 (24.35%) | -23 (-2.68%) | -22.4 (24.83%) | -29.8 (-101.35%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -12.85 (16.94%) | -15.47 (-10.92%) | -13.95 (-18.72%) | -11.75 (-8.50%) |
Book Value Per Share (BVPS) | 0.76 (-89.67%) | 7.37 (-45.54%) | 13.53 (-53.48%) | 29.08 (233.16%) |
Tangible Assets Book Value Per Share (TABVPS) | 4.77 (-60.77%) | 12.17 (-29.82%) | 17.34 (-44.17%) | 31.05 (198.18%) |
Enterprise Value Over EBIT (EV/EBIT) | -1 (66.67%) | -3 (0.00%) | -3 (-50.00%) | -2 |
Enterprise Value Over EBITDA (EV/EBITDA) | -0.57 (81.93%) | -3.13 (-6.64%) | -2.94 (-26.15%) | -2.33 |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 1.19 (-53.04%) | 2.53 (-44.28%) | 4.55 (-71.04%) | 15.71 (130.19%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$10,383,431 (-5.94%) | -$9,800,885 (-29.95%) | -$7,542,290 (-50.43%) | -$5,013,697 (-49.59%) |
Enterprise Value (EV) | $7,987,970 (-82.51%) | $45,679,023 (28.56%) | $35,531,243 (19.68%) | $29,687,478 |
Earnings Before Tax (EBT) | -$14,103,103 (3.26%) | -$14,577,768 (-20.55%) | -$12,092,776 (5.14%) | -$12,747,697 (-177.12%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$14,103,103 (3.26%) | -$14,577,768 (-20.55%) | -$12,092,776 (5.14%) | -$12,747,697 (-177.12%) |
Invested Capital | -$3,091,592 (-10.12%) | -$2,807,503 (-56.26%) | -$1,796,730 (-227.51%) | -$548,605 (-53.48%) |
Working Capital | $615,121 (-86.82%) | $4,666,685 (-36.20%) | $7,315,021 (-41.06%) | $12,410,241 (351.04%) |
Tangible Asset Value | $3,857,963 (-49.96%) | $7,709,123 (-17.78%) | $9,376,706 (-29.25%) | $13,254,150 (311.11%) |
Market Capitalization | $13,750,534 (-73.92%) | $52,731,352 (14.29%) | $46,138,584 (4.51%) | $44,146,524 |
Average Equity | $3,176,296 (-36.88%) | $5,032,292 (-44.93%) | $9,138,196 (-18.19%) | $11,170,024 (534.40%) |
Average Assets | $6,382,487 (-18.92%) | $7,872,093 (-23.02%) | $10,225,864 (-15.95%) | $12,166,440 (322.78%) |
Invested Capital Average | -$3,011,470 (-12.35%) | -$2,680,502 (-220.89%) | -$835,338 (-42.47%) | -$586,320 (41.97%) |
Shares | 844,627 (22.69%) | 688,399 (18.77%) | 579,630 (13.48%) | 510,790 (7.07%) |
